A curious but non-serious local side effect of inhaled iloprost: Sudden linear erythematous facial rash

Clinical and Experimental Dermatology

Volumn 34, Issue 8, 2009, Pages

  Feito Rodriguez M ^a   Floristan, U ^a   De Lucas Laguna, R ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ILOPROST;

ADOLESCENT; CASE REPORT; ERYTHEMA; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SKIN DEFECT;

CHILD; DRUG ERUPTIONS; FACIAL DERMATOSES; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; MALE; VASODILATOR AGENTS;

EID: 72549117026     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03679.x     Document Type: Letter

References (3)

1. Park MH. Advances in diagnosis and treatment in patients with pulmonary arterial hypertension. Catheter Cardiovasc Interv 2008 71 : 205 213.
2. Gomberg-Maitland M, Olschewski H. Prostacyclin therapies for the treatment of pulmonary arterial hypertension. Eur Respir J 2008 31 : 891 901.
3. Actelion Pharmaceuticals. Ventavis (Iloprost) Package Insert. San Francisco : Actelion Pharmaceuticals US, Inc, 2006.